IgG4-Related Disease

Retrospective Analysis of One Hundred Sixty-Six Patients

Hiroshi Sekiguchi, Ryohei Horie, Mio Kanai, Reina Suzuki, Eunhee S. Yi, Jay H Ryu

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Objective: To investigate clinical and pathologic aspects of IgG4-related disease (IgG4-RD) in non-Asian populations. Methods: We conducted a retrospective review of the medical records of patients with IgG4-RD who presented to an academic medical center from January 1994 to September 2012. Results: Among 166 patients identified, the median age at diagnosis was 61 years (interquartile range [IQR] 49–70 years), 75% were male, and 80% were white. The median number of organs involved was 2 (IQR 2–3). When organs were grouped according to anatomic system, the hepatopancreaticobiliary system was most commonly involved (77%). The median highest serum IgG4 level during the clinical course was 215 mg/dl (IQR 122–466). Forty-three patients (26%) had a normal serum IgG4 level. Seventy-nine pathology specimens were available for immunostaining. The median number of IgG4+ cells was 37 (IQR 25–82) per high-power field, with an IgG4+:IgG+ ratio of 0.50 (IQR 0.32–0.68). Among 151 patients who received medical therapy, 72 (48%) received steroid-sparing agents because of relapse, recurrence, or corticosteroid intolerance. Of the 66 patients who were newly diagnosed, started on corticosteroid monotherapy as the initial treatment, and followed up at our institution, 30 (45%) experienced relapse or recurrence despite an initial favorable response. The number of organs involved had a significant impact on time to relapse or recurrence, with a hazard ratio of 1.48 (95% confidence interval [95% CI] 1.12–1.93) (P < 0.01) in multivariate analysis. The standardized incidence ratio of malignancy was 4.5 (95% CI 1.5–7.5). Conclusion. IgG4-RD is a multisystem disorder that commonly affects older men and has a propensity for relapse, recurrence, and malignancy.

Original languageEnglish (US)
Pages (from-to)2290-2299
Number of pages10
JournalArthritis and Rheumatology
Volume68
Issue number9
DOIs
StatePublished - Sep 1 2016

Fingerprint

Immunoglobulin G
Recurrence
Adrenal Cortex Hormones
Confidence Intervals
Serum
Medical Records
Neoplasms
Multivariate Analysis
Cell Count
Steroids
Pathology
Incidence
Therapeutics
Population

ASJC Scopus subject areas

  • Immunology
  • Immunology and Allergy
  • Rheumatology

Cite this

IgG4-Related Disease : Retrospective Analysis of One Hundred Sixty-Six Patients. / Sekiguchi, Hiroshi; Horie, Ryohei; Kanai, Mio; Suzuki, Reina; Yi, Eunhee S.; Ryu, Jay H.

In: Arthritis and Rheumatology, Vol. 68, No. 9, 01.09.2016, p. 2290-2299.

Research output: Contribution to journalArticle

Sekiguchi, Hiroshi ; Horie, Ryohei ; Kanai, Mio ; Suzuki, Reina ; Yi, Eunhee S. ; Ryu, Jay H. / IgG4-Related Disease : Retrospective Analysis of One Hundred Sixty-Six Patients. In: Arthritis and Rheumatology. 2016 ; Vol. 68, No. 9. pp. 2290-2299.
@article{d122b0b4a6cc4553b61a4bd1d58fcc1d,
title = "IgG4-Related Disease: Retrospective Analysis of One Hundred Sixty-Six Patients",
abstract = "Objective: To investigate clinical and pathologic aspects of IgG4-related disease (IgG4-RD) in non-Asian populations. Methods: We conducted a retrospective review of the medical records of patients with IgG4-RD who presented to an academic medical center from January 1994 to September 2012. Results: Among 166 patients identified, the median age at diagnosis was 61 years (interquartile range [IQR] 49–70 years), 75{\%} were male, and 80{\%} were white. The median number of organs involved was 2 (IQR 2–3). When organs were grouped according to anatomic system, the hepatopancreaticobiliary system was most commonly involved (77{\%}). The median highest serum IgG4 level during the clinical course was 215 mg/dl (IQR 122–466). Forty-three patients (26{\%}) had a normal serum IgG4 level. Seventy-nine pathology specimens were available for immunostaining. The median number of IgG4+ cells was 37 (IQR 25–82) per high-power field, with an IgG4+:IgG+ ratio of 0.50 (IQR 0.32–0.68). Among 151 patients who received medical therapy, 72 (48{\%}) received steroid-sparing agents because of relapse, recurrence, or corticosteroid intolerance. Of the 66 patients who were newly diagnosed, started on corticosteroid monotherapy as the initial treatment, and followed up at our institution, 30 (45{\%}) experienced relapse or recurrence despite an initial favorable response. The number of organs involved had a significant impact on time to relapse or recurrence, with a hazard ratio of 1.48 (95{\%} confidence interval [95{\%} CI] 1.12–1.93) (P < 0.01) in multivariate analysis. The standardized incidence ratio of malignancy was 4.5 (95{\%} CI 1.5–7.5). Conclusion. IgG4-RD is a multisystem disorder that commonly affects older men and has a propensity for relapse, recurrence, and malignancy.",
author = "Hiroshi Sekiguchi and Ryohei Horie and Mio Kanai and Reina Suzuki and Yi, {Eunhee S.} and Ryu, {Jay H}",
year = "2016",
month = "9",
day = "1",
doi = "10.1002/art.39686",
language = "English (US)",
volume = "68",
pages = "2290--2299",
journal = "Arthritis and Rheumatology",
issn = "2326-5191",
publisher = "John Wiley and Sons Ltd",
number = "9",

}

TY - JOUR

T1 - IgG4-Related Disease

T2 - Retrospective Analysis of One Hundred Sixty-Six Patients

AU - Sekiguchi, Hiroshi

AU - Horie, Ryohei

AU - Kanai, Mio

AU - Suzuki, Reina

AU - Yi, Eunhee S.

AU - Ryu, Jay H

PY - 2016/9/1

Y1 - 2016/9/1

N2 - Objective: To investigate clinical and pathologic aspects of IgG4-related disease (IgG4-RD) in non-Asian populations. Methods: We conducted a retrospective review of the medical records of patients with IgG4-RD who presented to an academic medical center from January 1994 to September 2012. Results: Among 166 patients identified, the median age at diagnosis was 61 years (interquartile range [IQR] 49–70 years), 75% were male, and 80% were white. The median number of organs involved was 2 (IQR 2–3). When organs were grouped according to anatomic system, the hepatopancreaticobiliary system was most commonly involved (77%). The median highest serum IgG4 level during the clinical course was 215 mg/dl (IQR 122–466). Forty-three patients (26%) had a normal serum IgG4 level. Seventy-nine pathology specimens were available for immunostaining. The median number of IgG4+ cells was 37 (IQR 25–82) per high-power field, with an IgG4+:IgG+ ratio of 0.50 (IQR 0.32–0.68). Among 151 patients who received medical therapy, 72 (48%) received steroid-sparing agents because of relapse, recurrence, or corticosteroid intolerance. Of the 66 patients who were newly diagnosed, started on corticosteroid monotherapy as the initial treatment, and followed up at our institution, 30 (45%) experienced relapse or recurrence despite an initial favorable response. The number of organs involved had a significant impact on time to relapse or recurrence, with a hazard ratio of 1.48 (95% confidence interval [95% CI] 1.12–1.93) (P < 0.01) in multivariate analysis. The standardized incidence ratio of malignancy was 4.5 (95% CI 1.5–7.5). Conclusion. IgG4-RD is a multisystem disorder that commonly affects older men and has a propensity for relapse, recurrence, and malignancy.

AB - Objective: To investigate clinical and pathologic aspects of IgG4-related disease (IgG4-RD) in non-Asian populations. Methods: We conducted a retrospective review of the medical records of patients with IgG4-RD who presented to an academic medical center from January 1994 to September 2012. Results: Among 166 patients identified, the median age at diagnosis was 61 years (interquartile range [IQR] 49–70 years), 75% were male, and 80% were white. The median number of organs involved was 2 (IQR 2–3). When organs were grouped according to anatomic system, the hepatopancreaticobiliary system was most commonly involved (77%). The median highest serum IgG4 level during the clinical course was 215 mg/dl (IQR 122–466). Forty-three patients (26%) had a normal serum IgG4 level. Seventy-nine pathology specimens were available for immunostaining. The median number of IgG4+ cells was 37 (IQR 25–82) per high-power field, with an IgG4+:IgG+ ratio of 0.50 (IQR 0.32–0.68). Among 151 patients who received medical therapy, 72 (48%) received steroid-sparing agents because of relapse, recurrence, or corticosteroid intolerance. Of the 66 patients who were newly diagnosed, started on corticosteroid monotherapy as the initial treatment, and followed up at our institution, 30 (45%) experienced relapse or recurrence despite an initial favorable response. The number of organs involved had a significant impact on time to relapse or recurrence, with a hazard ratio of 1.48 (95% confidence interval [95% CI] 1.12–1.93) (P < 0.01) in multivariate analysis. The standardized incidence ratio of malignancy was 4.5 (95% CI 1.5–7.5). Conclusion. IgG4-RD is a multisystem disorder that commonly affects older men and has a propensity for relapse, recurrence, and malignancy.

UR - http://www.scopus.com/inward/record.url?scp=84983527687&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84983527687&partnerID=8YFLogxK

U2 - 10.1002/art.39686

DO - 10.1002/art.39686

M3 - Article

VL - 68

SP - 2290

EP - 2299

JO - Arthritis and Rheumatology

JF - Arthritis and Rheumatology

SN - 2326-5191

IS - 9

ER -